Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Influenza
- Influenza -Like Illness
- Influenza, Human
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Retrospective
Participation Requirements
- Age
- Between 65 years and 125 years
- Gender
- Both males and females
Description
This study will enroll facilities who participated in the adjuvanted influenza vaccine study in 2016-2017 to document the vaccine choice for the 2017-2018 influenza season through a survey. Additional facilities will be enrolled that did not participate to answer a survey responding to questions reg...
This study will enroll facilities who participated in the adjuvanted influenza vaccine study in 2016-2017 to document the vaccine choice for the 2017-2018 influenza season through a survey. Additional facilities will be enrolled that did not participate to answer a survey responding to questions regarding the vaccine choice for the 2017-2018 and 2018-2019 flu season. Both groups will also gather information on vaccination rates for residents and staff, policies and procedures, and influenza outbreaks. The facility will complete a profile and answer questions regarding influenza vaccination in their facilities for the 2017-2018 and 2018-2019 flu seasons. The study team will obtain data from the Centers for Medicare & Medicaid Services in 2019 to determine the study outcomes. None of the data used in the analysis will be linked to individual residents in facilities.
Tracking Information
- NCT #
- NCT03599739
- Collaborators
- Seqirus
- Brown University
- Investigators
- Principal Investigator: Stefan Gravenstein, MD, MPH Brown University Principal Investigator: Vincent Mor, PhD Brown University Principal Investigator: Pedro Gozalo, Phd Brown University Principal Investigator: H. Edward Davidson, PharmD, MPH Insight Therapeutics, LLC
Get Well Soon